Many people experience an itchy scalp at some point. It’s usually not a sign of a serious medical condition and can, in most ...

The FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new ...

Using a topical steroid on your face is a common one, but perioral dermatitis can also show up if you’re using thick or oily ...

The FDA approved dupilumab for the treatment of patients 12 years and older with chronic spontaneous urticaria who remain ...

If you have atopic dermatitis (eczema), this guide will help you prepare for what to except during your initial doctor's ...

Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

AD is a growing market with an impressive pipeline of new products from current and future players in the field.

Explore holistic approaches to treating the atopic triad in children—eczema, asthma, and allergies—with naturopathic ...

Raj Chovatiya, MD, PhD, MSCI, highlights promising research in atopic dermatitis focused on identifying patient subgroups for ...

On its way to generating sales of $14 billion in just its seventh full year on the market, Sanofi and Regeneron’s Dupixent ...

A new study published in the Journal of European Academy of Dermatology and Venerology showed that compared to patients on ...

Resubmission of the supplemental biologics license application provided more data on improvement in hives and itching in ...